Background. The objective of this study was to measure myocardial blood flow (MBF) in humans using 99m Tc-tetrofosmin and dynamic single-photon emission computed tomography (SPECT).
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INTRODUCTION
Myocardial perfusion imaging (MPI) using singlephoton emission computed tomography (SPECT) remains an important tool in the diagnosis and risk stratification of patients with coronary artery disease (CAD). 1 Although the conventional approach of visual assessment can be a direct and persuasive practice for diagnosing ischemia, it often fails to predict existence of homogeneous global reduction of myocardial perfusion due to flow limiting multi-vessel disease. [2] [3] [4] [5] A credible approach to overcome this limitation is to quantify regional myocardial blood flow (MBF) and coronary flow reserve (CFR) during exercise. 4, 5 Absolute quantification of regional MBF is a more sensitive approach for detecting CAD and flow-related abnormalities, and will become a critical component of cost-saving initiative for screening CAD patients for medical intervention and/or referral to cardiac catheterization. 6 Significant technical developments in recent years have increased the awareness of the clinical value of MBF quantification in humans. 6, 7 Recently, a number of studies using a dedicated cardiac SPECT camera were performed to calculate myocardial perfusion index (MPI) and CFR using commonly available SPECT radiotracers. [8] [9] [10] In this paper, we present the utility of dynamic cardiac SPECT to estimate the MBF and CFR in a rest/ stress protocol using 99m Tc-tetrofosmin with a conventional two-headed SPECT/CT camera (Infinia Hawkeye 4, GE Healthcare) and validate the method with 13 N-NH 3 PET in a population of 16 patients. Our method is unique in that we have employed the B-spline-based spatiotemporal reconstruction 11 of the dynamic data acquired in humans as the camera rotates continuously to capture the dynamics of the tracer activity in the myocardium and blood pool. To our knowledge, this is the first such study to quantify MBF in patients using a clinical two-headed SPECT/CT system and 99m Tctetrofosmin and to correlate it with MBF measured using 13 N-NH 3 PET.
METHODS
Sixteen patients (12 males, 4 females, mean age 73) with known or suspected CAD referred by cardiologists (EHB, YY, or AB) were recruited at the University of California San Francisco (UCSF) Imaging Center to study the clinical feasibility of the new rest/pharmacologically induced stress dynamic SPECT MPI continuous-acquisition protocol. Patient demographics and medical histories related to coronary risk factors were also assessed. All patients also underwent a dynamic 13 N-NH 3 PET study within 12 months (median 1 month and mean 3.3 months) of the dynamic SPECT study. Multiple modalities relevant to assessment of patients' normal/ abnormal condition are shown in Table 1 . Note that the same patient underwent two or more studies.
There were no revascularization procedures, percutaneous coronary intervention (PCI), balloon angioplasty or stent, or coronary artery bypass graft (CABG) surgery between the dynamic SPECT study and dynamic PET and/or diagnostic coronary angiography. Patients who had previous history of PCI and CABG were included in the study.
Informed verbal consents were obtained during the initial contact, and written consents were obtained prior to the scan. Patients received full information about the potential risk and benefit of their participation before signing the written consent. The study was approved by the Committee on Human Research (CHR), the Institutional Review Board (IRB) at UCSF, and the Human and Animal Research Committee (HARC) at Lawrence Berkeley National Laboratory (LBNL).
Imaging Protocols
Dynamic cardiac SPECT MPI. Single day low/ high-dose rest/pharmacologic stress (20 minutes/20 minutes) protocol was performed using a dual head SPECT/CT system The scanner detector heads equipped with low-energy high-resolution (LEHR) collimators were configured in the Hmode (i.e., oriented 180°to each other) for the dynamic acquisition. Two views with a 3°increment every second and a total of 120 projection images (60 views from each camera head) per minute were acquired. The rotation speed of each camera head was 2 minutes per rotation. Projection data were binned into 128 9 128 detector pixels having a pixel size of 4.4 9 4.4 mm 2 .
The rest dynamic SPECT acquisition began immediately prior to the radiotracer IV injection with patients lying in the supine position. Once the scanner heads (configured in Hmode) began rotating, each patient manually received an IV bolus injection (10-20 seconds duration) of approximately 370 MBq (10 mCi) of 99m Tc-tetrofosmin (Myoview; GE Healthcare). For the stress study, each patient was given a 0.4 mg IV injection of the stress agent regadenoson (Lexiscan; Astellas Pharma, Inc.) followed by a dose of 925 MBq (25 mCi) of 99m Tc-tetrofosmin approximately 30-60 seconds later. Heart rate, blood pressure, and oxygen saturation were monitored, and 12-lead electrocardiograms (ECG) were recorded every minute after the regadenoson injection.
PET perfusion imaging. All 16 patients also underwent dynamic 13 N-NH 3 PET rest/stress MPI scans (15 minutes/15 minutes) using a PET/CT scanner (Discovery VCT, GE Healthcare) using an established protocol for clinical cardiac PET-MPI studies at our institution. This protocol includes a rest scan with 740 MBq (20 mCi) of 13 N-NH 3 , and then pharmacologic stress with 740 MBq (20 mCi) of 13 N-NH 3 using regadenoson as used in the dynamic SPECT studies. Like with the SPECT studies, transmission CT was acquired for each patient for image registration and attenuation correction.
Image Reconstruction
The dynamic SPECT data for each patient were reconstructed using the 4-dimensional maximum likelihood expectation maximization (ML-EM) algorithm applicable to spatiotemporal image reconstruction in emission tomography, a software package developed by LBNL/UCSF 12 for the continuous rotation two-headed detector system. 13 Since the data were distributed over a single energy window with a photo peak at 140 keV, scattering correction was not applied. However, collimator response and partial volume correction were modeled explicitly during iterative reconstruction by incorporating the point-spread-function (PSF) in the system matrix. Blurring due to cardiac, respiratory, or patient motion were neglected. But cross-contamination due to spillover between myocardium and left and right ventricles was corrected during fitting of the time activity curves (TACs) to compartment models (see below).
All SPECT attenuation-corrected reconstructed dynamic data were sampled uniformly at 5 seconds intervals. A Gaussian filter (with kernel size = 9 and SD = 1.7 mm corresponding to 4.0 mm full-width half-maximum (FWHM)) was applied to each of the reconstructed frames of the 3D SPECT data.
Similarly, PET data were reconstructed and post-processed using vendor-provided 2D filtered back projection software tool. The processed PET images were sampled with 5 seconds duration for the first 3 minutes, 60 seconds for the next 2 minutes, and 5 minutes thereafter with a total of 40 dynamic frames for kinetic analysis.
Estimation of Perfusion and Myocardial Blood Flow
The myocardium was oriented along the long-axis/shortaxis view and subdivided into 17 segments from basal through mid-cavity to apical regions using the PMOD Cardiac PET Modeling Tool (PCARDP) (PMOD Technologies, Zurich, Switzerland). The time activity curves (TACs) for all segments as well as activity concentrations of left and right ventricular blood pools for each rest-stress pair were extracted. The leftover background activity in the stress data from the rest study was subtracted. The corresponding uptake and washout rates were estimated using a one-tissue compartment model for 99m Tc-tetrofosmin, which has been shown to be sufficient for
where C m (t) and C lv are the activities of the myocardium and left ventricular cavity, while K 1 and k 2 are the tracer uptake and wash-out rates, respectively. The double spillover correction 14 in the myocardium from the left and right ventricle was also implemented. To allow the fitting of the data over an extended period, an exponential metabolite correction was included as described by van den Hoff et al, 16 with a delay time t 0 = 0.48 minutes and half-life T 1/2 = 6.69 minutes. The extraction-corrected MBF was then calculated by using the estimated K 1 values from 13 N-NH 3 .
17
For the quantification of regional MBF (F) with dynamic SPECT, the measured K 1 values for 99m Tc-tetrofosmin were incorporated into the Renkin-Crone (RC) model of the Krogh cylinder. [18] [19] [20] The relationship between K 1 of 99m Tc-tetrofosmin and estimated MBF (F) was assumed to follow a generalized RC model,
where A and B are the free parameters that were estimated by fitting the flow values estimated from dynamic 13 N-NH 3 PET. This model (Eq. 2) was compared with the equivalent model assuming that the permeability surface-area product (PS) (mL/min/g) of the blood capillaries depends on the flow,
Here PS = a * F ? b with a and b to be determined by fitting the experimental K 1 data with the flow measured with 13 N-NH 3 PET.
Nine out of sixteen patients were used for the estimation of the parameters A and B, or a and b. The K 1 values in three vascular territories (LAD, RCA, and LCX) for 99m Tc-testrofosmin using dynamic SPECT were plotted against the corresponding extraction-corrected flow values by using the relation originally obtained by Schelbert et al 17 for 13 N-NH 3 . A best fit was obtained with a weighted least-squares algorithm. After estimating the extraction parameters A and B for 99m Tc-tetrofosmin, the territorial MBFs were calculated in Eq. 2 using a nonlinear fixed-point iteration method. A similar fitting method was employed for the estimation of a and b in Eq. 3.
Method Validation
Our method of validation was similar to the one originally applied for the validation of 13 N-NH 3 PET. 17 Our working hypothesis throughout this study was that the MBF estimated with SPECT quantitatively agrees with that of PET irrespective of patient's pathophysiological condition. An independent cohort of seven patients was used to correlate the MBF using 99m Tc-tetrofosmin SPECT to MBF using 13 N-NH 3 PET for both rest and stress data. The estimated MBF using 99m Tctetrofosmin SPECT was plotted against the MBF using 13 N-NH 3 PET. Bland-Altman plots were evaluated to determine the limits of agreement. To assess the clinical significance of the data the coronary flow reserve (CFR), defined as the ratio of absolute blood flow during stress to that at rest, were calculated and correlated.
Based on the clinical findings (Table 1) , all 16 patients were evaluated by one of us (EHB) and classified them into normal and abnormal subgroups. The corresponding CFR values estimated with PET and SPECT were compared.
Statistical Analysis
All estimated values are expressed as mean ± SD. All MBF values are expressed in mL/min/g. Fits were assessed by calculating the R 2 -value to test the goodness of fit. Pearson correlation coefficients for the MBF and CFR values estimated with dynamic SPECT and dynamic PET were computed to assess the linear regression relationships. Whenever necessary, P values were calculated using two-tailed t test to measure the statistical significance. Unless explicitly stated otherwise, any difference was considered statistically significant if the P value is greater than .05. Any P value less than .001 is reported as P \ .001. The agreement between the PET and SPECT methods were also analyzed using a Bland-Altman plot. Welch's two-sample t test was performed to recognize the deviation of the estimated mean values between PET and SPECT. Analysis of variance (ANOVA) was performed to compare the statistical equivalency of the two fitting models (Eqs. 2, 3). All statistical calculations were performed using the open-source statistical package R (http://www. R-project.org/).
RESULTS
Patients' characteristics (demographics and medical history) are listed in Table 2 . Among the 16 patients studied with dynamic SPECT, 9 had evidence of CAD or myocardial ischemia either on coronary angiography or conventional SPECT MPI and/or dynamic PET MPI. Dynamic 13 N-NH 3 PET revealed that eight patients had flow abnormalities.
Estimation of MBF Using Dynamic SPECT with 99m
Tc-Tetrofosmin
The K 1 -values in the three major coronary territories estimated from 99m Tc-tetrofosmin for 9 patients both at rest and during stress were plotted against those estimated from 13 N-NH 3 PET (Figure 1 ). The estimated K 1 -values for 13 N-NH 3 were used to obtain the absolute MBF by incorporating the known fitting parameters, A = 0.096, B = 1.083 for 13 N-NH 3 . 17 In Figure 2 , the estimated K 1 -values for 99m Tc-tetrofosmin were plotted against these corresponding absolute flow values for 13 N-NH 3 . The best fit to Eq. 2 provided the parameters A = 0.91 ± 0.11, B = 0.34 ± 0.20 (R 2 = 0.49) for 99m Tc-tetrofosmin. The insert shows the comparison between the two models (Eq. 2-full line, Eq. 3-dotted line). In the latter model, the capillary PS value was found to be (a) * F ? (b) = (0.091 ± 0.10) * F ? (0.32 ± 0.16). The value of a is comparable to the value found previously (a = 0.069) for 99m Tc-tetrofosmin in a porcine model. 9 Furthermore, an ANOVA test revealed that there was no significant difference between the two fits (P \ .001).
MBF Correlation
To assess the accuracy of the derived SPECT flow values, the MBF in three major coronary territories (LAD, RCA, and LCX) both at rest and during stress estimated with 99m Tc-tetrofosmin SPECT were plotted in Figure 3A against the flow estimates measured with 13 N-NH 3 PET for an independent cohort comprised of 7 patients. The range of flow values was 0.44 to 3.81 mL/ min/g. The Pearson correlation coefficient was found to be r = 0.71 (P \ .001). A Bland-Altman analysis for the limits of agreement of the estimated MBF between the two modalities is shown in Figure 3B . There is a systematic bias of the mean difference of ?0.20. The 95% confidence interval lied between ?1.96 SD = 1.31 and -1.96 SD = -0.79.
Individual patient-to-patient correlation of MBFs estimated with the two modalities for 6 patients in an independent cohort of 7 patients is shown in Figure 4 . All correlations are statistically significant (P \ .001) with (min, max) = (0.76, 0.96). Note that, a high correlation only indicates a qualitative agreement and does not necessarily imply the quantitative concordance between the MBFs. This is reflected in the regression coefficient, i.e., the slopes of the trend lines deviate from the ideal value of one. Figure 5 shows a typical example of time activity curves (TACs) for the regional myocardial segments, and left and right ventricular blood pools at rest (A) and during stress (B) for a patient who had a known anterior wall defect determined with conventional SPECT MPI. Also shown are the late time images (12 minutes after injection of 99m Tc-tetrofosmin) for a mid-ventricular slice at rest in the short axis (C), vertical long axis (D), horizontal long axis (E), and RV-LV blood pool (F) at 60 seconds after tracer injection. The CFR values from both dynamic SPECT and PET were abnormal in those areas showing myocardial perfusion abnormalities with conventional SPECT MPI.
CFR Correlation
The correlation plot between CFR estimates obtained with 99m Tc-tetrofosmin SPECT and with 13 N-NH 3 PET for the same set of data ( Figure 3 ) is shown in Tc-tetrofosmin using the model
to the experimental data (filled circles, black) (R 2 = 0.49) for the subgroup of 9 patients at rest and stress. The best fit curve gave the extraction parameters A = 0.91 ± 0.11; B = 0.34 ± 0.20 for 99m Tc-tetrofosmin. Inset comparison of the two models (1)
(bottom curve). In model (2) 
DISCUSSION
Our study assessed the feasibility of quantifying regional MBF using dynamic SPECT with a conventional two-headed SPECT camera and a commonly used myocardial perfusion agent 99m Tc-tetrofosmin. The method was validated by correlating the flow measured using 99m Tc-tetrofosmin dynamic SPECT with the flow obtained by 13 N-NH 3 PET. Despite the poor first past extraction of 99m Tc-tetrofosmin by the myocardium, models (Eqs. 2, 3) were applied with 13 N-NH 3 PET data as the basis for blood flow measurements. This permitted the absolute quantification of MBF using dynamic SPECT with 99m Tc-tetrofosmin. Unlike a dedicated cardiac SPECT camera with solid-state detectors, the conventional two-headed SPECT camera is readily available and widely used in the nuclear medicine community; hence it is possible to reproduce the method on clinically installed systems. [21] [22] [23] There is a greater degree of MBF variability; even for a healthy cohort of normal patients the baseline MBF is not constant. 24 Accurate measurement of MBF thus adds an extra dimension to the detection of CAD as well as the evaluation of cardiac pathophysiology in other conditions. For an ideal tracer such as 15 O-H 2 O, vascular and cellular permeability and intercellular diffusion is very high and the perfusion index 8 alone presents a good quantitative measure of regional perfusion and myocardial viability. However, 99m Tc-tetrofosmin has a low extraction fraction at high flow rates resulting in smaller differences in the uptake between high and low flow regions. The absolute flow and CFR therefore present a better measure of coronary vascular reactivity and, excluding other confounding conditions, the possibility of quantitative diagnosis of CAD. Both 13 N-NH 3 and 99m Tc-tetrofosmin are taken up by the myocardium in proportion to the coronary blood flow. The metabolic changes and thus rate-limiting process of 13 N-NH 3 in the myocardium are fairly well understood, and are commonly modeled by a two-tissue compartment model. 15 The first-pass myocardial extraction fraction of NH 3 is relatively high, while 99m Tctetrofosmin has a first-pass myocardial extraction fraction of only 54% 25 with prolonged cellular retention. Although 99m Tc-tetrofosmin is bound to mitochondria, there is no known further metabolic utilization within cardiac myocytes. In this study, a one-tissue compartment model was used to assess the time-varying activity of 99m Tc-tetrofosmin as used previously for 99m Tcsestamibi. 8, 26 The flow-dependent PS parameters found in our study (a) * F ? (b) = (0.091 ± 0.10) * F ? (0.32 ± 0.16) are similar to the parameters obtained by Wells et al for 99m Tc-tetrofosmin in a porcine model. 9 The correlation of MBF estimated with 99m Tctetrofosmin SPECT and 13 N-NH 3 PET was statistically significant, r = 0.71 (P \ .001). However, the corresponding CFR correlation was moderate (r = 0.39) due to considerable data scatter about the regression line, yet statistically significant (P = .037). This could be partly due to the long-time interval between PET and SPECT studies (mean 3.3 months). The correlation of global CFR (r = 0.59) was somewhat better, possibly because of higher counts statistics. Our working hypothesis throughout this study was that MBF measured from SPECT quantitatively agrees with that measured from PET irrespective of patient's normal/abnormal condition. This assumption may be plausible in theory. But, in practice, it may be difficult to maintain identical patient physiological conditions, such as heart rate, perfusion pressure, myocardial viability, etc., in two studies within the span of 3 months. Tc-tetrofosmin SPECT using the parameters in Eq. 2 as described in Figure 2 In Figure 7 we compared the statistics of the absolute CFRs estimated with 13 N-NH 3 PET and 99m Tc-tetrofosmin SPECT in subgroups of normal (N = 7) and abnormal (N = 9) patients. We included all patients in these two heterogeneous groups partly due to a small sampling population comprised of only 16 patients who had both dynamic SPECT with 99m Tctetrofosmin and dynamic PET with 13 N-NH 3 . The estimated sample mean value of CFR in normal patients was 2.99 ± 0.91 with PET compared to 2.96 ± 1.39 with SPECT. Welch's two-sample t test showed the difference between means was not statistically significant (P = .048). However, the mean CFR value in the group of abnormal patients was 1.72 ± 0.51 with PET and 2.47 ± 1.82 with SPECT, and the difference was significant (P = .51). The mean CFR values still remained below the normal/abnormal borderline of 2.5 (dotted line, red). In view of the considerable data scatter of the SPECT flow estimates compared to the PET estimates, the accuracy of the SPECT approach to distinguish regions of normal and abnormal appears to be low. However, note that there were a few CFR data points in abnormal patients that were physiologically high in this patient cohort, and should be excluded. The corrected mean CFR with SPECT ( Figure 7 , SPECT*), after removing those outliers (CFR [ 5), was 2.19 ± 0.82. The difference between corrected mean CFR using dynamic SPECT with 99m Tc-tetrofosmin and PET with 13 N-NH 3 was not significant with the level of confidence (P = .2). Table 3 presents the summary of statistical comparisons of CFR measurements between SPECT and PET in the subgroups of normal and abnormal patients.
In addition to a small sample size, there are other confounding factors-such as differences in sensitivity and resolution between PET and SPECT cameras-that could influence the estimation of the model parameters, A and B or (a) and (b) for 99m Tc-tetrofosmin. The estimation of the MBF estimation could also be adversely affected by a reduction in spatial resolution due to the large radius of rotation of the SPECT camera, the inability to perform subtraction-based scatter correction, and/or image blurring due to cardiac and respiratory motion on both SPECT and PET. Poor CFR correlation may be related in part to the composition of the patient population, which in addition to normal subjects, included patients with coronary artery disease, ischemic, and non-ischemic cardiomyopathies, patients with left ventricular hypertrophy, and prior CABG and PCI. Studies on patients with cardiomyopathies have often shown a blunted regional MBF and coronary flow reserve. 27 The poor CFR correlation between PET and SPECT in abnormal patient cohort may be the reflection of our biased classification, which was based on SPECT MPI and dynamic PET data. It is generally accepted that coronary angiograph (CA) is the gold standard for defining flow-related normal/abnormal coronary anatomy. However, in our studies we were not able to use CA because this was not performed in all patients. Tc-tetrofosmin SPECT in a heterogeneous group of normal (N = 7) and abnormal (N = 9) patients. (A) The estimated sample mean value of CFR in normal patients was 2.99 ± 0.91 with PET compared to 2.96 ± 1.39 with SPECT. The difference between means in the two methods was not statistically significant (P = .048). However, the mean CFR value in abnormal patients was 1.72 ± 0.51 with PET and was 2.47 ± 1.82 with SPECT, and the difference was significant (P = 0.51). The normal/abnormal CFR border line is 2.5. SPECT* represents the SPECT CFR for the abnormal group with the removal of outliers (n = 5), i.e., the data points with CFR [ 5 were excluded in the calculation. The corrected estimated sample mean was 2.19 ± 0.82 and the difference is not statistically significant with the level of confidence (P = .2).
There are other non-flow limiting factors, possibly related to the anatomy, hormone levels, and metabolism of the specific cardiac pathophysiology, which could also influence endothelial function at the level of the arterioles and pre-capillaries, the site of the resistance vessels, and so may determine the tracer uptake and differential response to hyperemia in the regulation of MBF in PET and SPECT.
NEW KNOWLEDGE GAINED
It is feasible to quantify regional MBF in humans using dynamic SPECT with a conventional two-headed SPECT camera and 99m Tc-tetrofosmin. Dynamic cardiac SPECT has the potential to better diagnose several cardiac myopathies that demonstrate blunted MBF. A continuous dynamic image of the tracer uptake provides a means for observing the time after tracer injection when the contrast of the myocardium to background is optimum.
CONCLUSIONS
In spite of immense clinical impact of quantifying MBF, only a few human studies for quantification of MBF with SPECT have been reported. Our study demonstrated the feasibility of measuring MBF using a widely used clinical two-headed SPECT camera. Our method was correlated with 13 N-NH 3 PET. Additional studies applying this method to a larger patient population including clinically defined homogenous groups will improve the model parameters and accuracy of the MBF measurement. Finally, precise implementation of kinetic analysis, better segmentation techniques by generating images of different tissue types based on their tracer uptake behavior 28 and removing undesired liver and background activity would improve the accuracy of the method. 
